Delta Financial Group, Inc. Gilead Sciences, Inc. Transaction History

Delta Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$71.58 - $87.29 $13,385 - $16,323	-187 Reduced 4.4%	4,066 $298,000
Q4 2023 Jan 18, 2024	SELL	$73.27 - $83.09 $37,294 - $42,292	-509 Reduced 10.69%	4,253 $345,000
Q3 2023 Oct 31, 2023	BUY	$73.94 - $80.67 $352,102 - $384,150	4,762 New	4,762 $357,000
Q1 2023 Apr 25, 2023	BUY	$77.31 - $88.08 $463 - $528	6 Added 0.21%	2,912 $242,000
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $181,101 - $259,999	2,906 New	2,906 $247,000

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Delta Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Delta Financial Group, Inc. with notifications on news.